Previous studies have shown that FDG uptake by the BM is increased in several types of cancer and that it correlates with the levels of serum cytokines, C-reactive protein, and other hematologic parameters, which may be indicative of the BM activation in response to tumor-associated inflammation9–11. This evidence concerns the gene CRP and cancer.